CoCensys Inc.: The Irvine biopharmaceutical company reported...

CoCensys Inc.: The Irvine biopharmaceutical company reported a net loss of $6.1 million, or 27 cents a share, for the first quarter, compared with a net loss of $5.6 million, or 26 cents a share, for the comparable period last year. Revenue increased 13% to $1.8 million from $1.6 million.